Evidence map›Paper›PMID 8083352›Full record

ArticleThe Journal of clinical investigation1994

Internalization of type 1 complement receptors and de novo multivesicular body formation during chemoattractant-induced endocytosis in human neutrophils.

M Berger, E Wetzler, J T August, A M Tartakoff

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in The Journal of clinical investigation, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

M BergerDepartment of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106.
E Wetzler
J T August
A M Tartakoff
Case Western Reserve University · USJohns Hopkins Medicine · USUniversity School · US

Funding

COMPLEMENT RECEPTOR EXPRESSION ON NEUTROPHILSR01AI022687 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BERGER, MELVIN · 1987 to 2000
$255k
STRUCTURE AND FUNCTION OF GLYCOINOSITOLP01DK038181 · NIDDK · CASE WESTERN RESERVE UNIVERSITY · PI TARTAKOFF, ALAN MICHAEL · 1987 to 1996
–
NCRR NIH HHS RR05410-29NIAID NIH HHS AI22687NIDDK NIH HHS DK38181
6 · The paper itself

Abstract

Upon activation of human neutrophils by chemoattractants, functionally important proteins are rapidly transported from intracellular granules and storage vesicles to the plasma membrane. This is accompanied by a marked increase in the rate of endocytosis and by ligand-independent internalization of type 1 complement receptors (CR1). To define the pathway of endocytosis, we used gold-conjugated BSA in a pulse-chase protocol. This tracer was initially internalized into small endocytic vesicles which rapidly traversed the cytoplasm and coalesced to form large, conspicuous multivesicular bodies. Within 5 min after addition of the chemoattractant, multivesicular bodies contained > 60% of the cell-associated BSA-gold. CR1 colocalized with the endocytic tracer in both the early endosomes and multivesicular bodies. In unstimulated cells, there was much less uptake of BSA-gold and multivesicular bodies were rarely seen. Using the acidotropic amine, DAMP, and anti-DNP antibodies, we found that the multivesicular bodies were acidified but the early endosomes did not concentrate DAMP. Neither the early endosomes nor the multivesicular bodies initially contained the lysosomal membrane antigens hLAMP 1 or 2, but hLAMP-positive structures subsequently joined the multivesicular bodies. The rapid activation of the endocytic pathway upon stimulation of neutrophils allowed us to visualize the de novo formation and maturation of multivesicular bodies. Our observations suggest that vesicles containing ion pumps and acid hydrolases fuse with multivesicular bodies, giving them characteristics of lysosomes, and that these are the probable sites of degradation of CR1. The observations do not support models which would require transport of CR1 from multivesicular bodies to defined, pre-existing lysosomes for degradation.

Indexed as

EndocytosisAdamantaneHumansIntracellular MembranesIn Vitro TechniquesLysosomesMembrane ProteinsMicroscopy, ElectronMicroscopy, ImmunoelectronNeutrophilsN-Formylmethionine Leucyl-PhenylalanineOrganellesPinocytosisReceptors, ComplementSerum Albumin, Bovine2,4-diamino-5-adamantyl-6-methylpyrimidineAdamantaneMembrane ProteinsN-Formylmethionine Leucyl-PhenylalanineReceptors, ComplementSerum Albumin, Bovine

Identifiers

PMID8083352
PMCPMC295175
OpenAlexW2036277859

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.